Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000146999 | SCV000309113 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Laboratory for Molecular Medicine, |
RCV000146999 | SCV000539980 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF |
Mendelics | RCV000986824 | SCV001135961 | benign | Meier-Gorlin syndrome 2 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001511200 | SCV001718403 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001511200 | SCV001901284 | benign | not provided | 2018-07-09 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000986824 | SCV002029314 | benign | Meier-Gorlin syndrome 2 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001511200 | SCV005245397 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000146999 | SCV000194336 | likely benign | not specified | no assertion criteria provided | clinical testing |